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Abstract
Background Acute psychological stress can produce sig-
nificant hemoconcentration as well as prothrombotic
changes in blood, both of which may have potentially
harmful effects on the cardiovascular system. It is unclear
whether these effects are independent or have influence on
each other.
Purpose This review discusses research investigating the
effects of acute psychological stress on hemoconcentration
and hemostasis and explores future directions for psycho-
hematology research. Physiology, associations with cardio-
vascular disease, and relationships between acute
psychological stress are discussed independently for hemo-
concentration and hemostasis, followed by an examination
of the effects of stress-hemoconcentration on hemostasis.
Conclusions Traditional methods of adjusting for stress-
hemoconcentration effects (e.g., calculated plasma volume
or hematocrit level corrections) may not be appropriate
when examining stress-induced changes in hemostasis. The
effects of acute stress on hemostasis should be examined in
conjunction with hemoconcentration.
Keywords Hemostasis . Hemoconcentration .
Cardiovascular disease . Psychological stress
Introduction
Cardiovascular disease is the underlying cause of 36% of
all deaths in the USA, making it the nation’s number one
killer, with coronary heart disease (CHD) being the primary
cause of death [1]. Several risk factors have been identified
for CHD, but five have been recognized as conferring the
most risk: high blood pressure, elevated serum cholesterol,
body mass index, diabetes, and smoking [2]. However,
these traditional risk factors do not fully explain CHD risk
[3]. Psychological stress is one factor purported to explain
additional CHD risk. For example, in the INTERHEART
study [4], individuals with myocardial infarction reported
more financial stress, more stress at home and at work, and
a greater number of major life events in the previous year
compared to controls. However, physiological mechanisms
linking stress to CHD have yet to be delineated fully. One
possible mechanism through which stress may be linked to
CHD is through adverse effects on hemostasis, which is the
arrest of bleeding by the physiological properties of
vasoconstriction and coagulation or the interruption of
blood flow through any vessel or to any anatomical area,
and hemostatic processes such as platelet function [5, 6],
hemorheology [7–9], and coagulation [10, 11]. In fact,
elevations in several factors involved in hemostasis, such as
fibrinogen, D-dimer, von Willebrand factor, and factor VII
(FVII), FVIII, FIX, FXI, and FXII, have been reported as
heightened risk markers for CHD [12, 13].
The initiation of acute coronary syndromes (especially
myocardial infarction) and acute atherothrombotic events in
the coronary tree has been linked to acute psychosocial
stress that can result from negative emotions, taxing social
situations, and traumatic events [11]. Several pathophysio-
logical mechanisms have been suggested, including hemo-
concentration (i.e., when the ratio of blood cells to plasma
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increases), alterations in blood rheology [7], vascular
endothelial dysfunction coupled with vasoconstriction,
proinflammatory cytokine release, autonomic imbalance
(e.g., alterations in heart rate variability), and activation of
the coagulation cascade as well as indirectly through
changes in health behaviors [14–16]. The disruption of the
hemostatic balance (i.e., balance between clot formation and
clot dissolution) is a critical factor in atherosclerotic develop-
ment and initiation of acute coronary syndromes. After plaque
rupture, a vessel occlusion is more likely if the ratio of
prothrombotic activity (i.e., promoting clot formation) to
fibrinolytic activity (i.e., promoting clot dissolution) is high.
During acute psychological stress, both prothrombotic and
fibrinolytic activities increase, but with the former to a greater
extent than the latter [10]. In a healthy person, such a
response is physiologically normal. However, this type of
response could have life-threatening effects in a patient with
CHD because stress-hypercoagulability seems to be exag-
gerated in these patients [17] and could add to hypercoag-
ulability initiated after plaque rupture. Therefore, risk
increases for the formation of a clot large enough to critically
occlude the coronary artery. The ensuing net hypercoagula-
bility resulting from acute psychological stress may put an
individual at a greater risk for coronary thrombosis after
plaque disruption and thus contribute to acute coronary
syndromes [10, 11]. Other crucial factors suggested to
accompany hypercoagulation are stress-induced hemocon-
centration [18] and increased blood viscosity [9, 19], both of
which exacerbate the shear stresses imposed by atheroscle-
rotic plaques and plaque ruptures [7]. Elucidation of how
these mechanisms occur is central to understanding the
relationship between stress and CHD.
The purpose of this review is to provide an update on the
state of the research investigating the effects of acute
psychological stress on hemoconcentration and hemostasis
and to explore future directions for psychohematology research.
This review has two main sections: “Hemoconcentration” and
“Hemostasis”. The first section provides an overview of
hemoconcentration with a discussion of physiology, association
with cardiovascular disease, and relationships between hemo-
concentration and acute psychological stress. The second
section is organized similarly, providing an overview of
hemostasis with a discussion of physiology, association with
cardiovascular disease, and relationships between hemostasis
and acute psychological stress, with particular emphasis on
coagulation. Finally, studies examining the effects of stress-
hemoconcentration on hemostasis are reviewed and future
directions are discussed.
Research articles with human participants were identified
through the use of a PUBMED search and through checking
the references of these sources. The following keywords were
used in various combinations for searching: psychological
stress, mental stress, hemoconcentration, plasma volume,
hemostasis, blood coagulation, and cardiovascular disease.
Given that the focus of this review is on acute stress, articles
were then examined to exclude those focusing on naturalistic
stressors (e.g., earthquakes), chronic stress, vital exhaustion, or
related concepts. Additionally, a wide variation in methodol-
ogy existed among acute stress studies, making a systematic
review difficult. Therefore, the review is narrative in nature.
Hemoconcentration
Hemoconcentration refers to conditions in which the ratio
of cellular components (principally red blood cells) of the
blood to the plasma volume increases [7]. Hemoconcentra-
tion mainly occurs in two ways. First, plasma volume can
remain constant while the number of red blood cells
increases. This condition is seen in polycythemia vera, a
rare tumorous condition in which red blood cells are
produced to a greater extent than normal [20] and in
secondary polycythemia which is associated with altitude
sickness [21]. Second, and more commonly, hemoconcen-
tration occurs when the number of red blood cells remains
constant while plasma volume decreases. This condition
has been variously referred to as ‘stress’ polycythemia,
relative polycythemia, pseudopolycythemia, spurious poly-
cythemia, or stress-hemoconcentration [7, 22, 23]. Figure 1
depicts stress-hemoconcentration that occurs when plasma
moves or shifts from the vascular compartment into
interstitial spaces during acute psychological stress pro-
duced by various laboratory stressors (e.g., mental arith-
metic, Stroop color–word recognition test, cold pressor test,
and public speaking). Early studies of plasma volume shifts
demonstrated this phenomenon during various psycholog-
ical states such as emotional stress [24] and anxiety [25].
Additionally, acute psychological stress reliably elicits
plasma volume losses from the vasculature [26].
Hemoconcentration Assessments
Plasma Proteins
One indicator of stress-hemoconcentration is an increase in
the concentration of plasma proteins, such as serum
albumin. Plasma passes easily into interstitial spaces
through minute openings or pores in the capillaries. On
the other hand, plasma proteins are large and pass through
these pores with great difficulty, if at all [7]. Specifically,
molecules greater than 69 kDa, including plasma proteins,
seem to be unable to passively pass through capillary pores
[27] and, as such, are susceptible to hemoconcentration
[28]. Notably, the presence of these large molecules creates
a large colloidal osmotic pressure gradient. Colloid osmotic
pressure refers to the force that occurs when particles
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cannot diffuse equally over intra- and extracapillary fluids.
In the case of stress-hemoconcentration, which is facilitated
by an acute increase in blood pressure and a net efflux of
plasma into the interstitial spaces, the plasma protein
concentration is greater inside the blood vessels than in
the interstitial fluid surrounding the blood vessels, resulting
in a constant pressure gradient for fluid to be drawn back
into the blood vessels when blood pressure returns to
normal. Therefore, an acute increase in colloid osmotic
pressure as well as in the plasma protein concentration can
signify stress-hemoconcentration [7, 9, 29].
A consequence of an increase in colloid osmotic
pressure and plasma protein concentration is altered flow
properties of the blood. Specifically, blood becomes thicker
and more viscous. When plasma shifts into interstitial
spaces, the resultant increase in total plasma protein
concentration causes an increase in blood and plasma
viscosity. Whole blood viscosity, in turn, is determined
mainly by plasma viscosity, the deformability of the red
cells, the extent of cellular aggregation, and the concentra-
tion of suspended particles, particularly fibrinogen. In-
creased blood viscosity ultimately contributes to blood
pressure by increasing total peripheral resistance [7, 30].
Hematocrit, Hemoglobin, and Plasma Volume
Two other commonly reported indicators of the extent of stress-
hemoconcentration are hematocrit and hemoglobin. Hematocrit
is the percentage of whole blood that is made up of red blood
cells [7]. In healthy adults during rest, hematocrit ranges from
40% to 55% in males and 36% to 48% in females [31].
Hemoglobin concentration is closely related to hematocrit.
Hemoglobin is an oxygen-carrying molecule present in red
blood cells. Red cells are able to carry up to 34 g of
hemoglobin per 100 ml of cells [20]. Consequently, the total
amount of hemoglobin is determined by hematocrit and the
quantity of hemoglobin in each cell. Normal adult concen-
trations range from 13 to 18 g/dl in males and 12 to 16 g/dl in
females. In healthy individuals, the amount of hemoglobin
carried by each red blood cell is near the maximum (i.e., 34 g
per 100 ml of cells), so changes in hematocrit yield near-
parallel changes in hemoglobin concentration [20].
Plasma viscosity and total plasma protein concentration are
considered direct measures of hemoconcentration. Calculated
plasma volume from hematocrit and hemoglobin, on the other
hand, is an indirect measure of hemoconcentration. Calculated
plasma volume is very closely related to plasma viscosity;
therefore, correction factors based on calculated plasma
volume are often used to assess hemoconcentration [7, 32].
Early researchers assumed that, under conditions of constant
red cell volume, a decrease in hematocrit corresponded to a
proportionally equal increase in plasma volume [33, 34].
Research in the 1970s, however, suggested that hematocrit
and plasma volume were not as proportional as were earlier
predicted [35], and therefore hematocrit has not been shown
to be directly related to plasma volume. Rather, hematocrit is
the ratio of red cell volume to blood volume. For changes in
hematocrit to accurately reflect changes in plasma volume, it
is necessary that two assumptions are met [36]. First, the
number of red blood cells must remain constant. In other
words, red blood cells should not be added to or removed
from the blood during the period under examination. Second,
the volume of red blood cells must remain constant.
However, as plasma volume decreases, the concentration of
plasma proteins increases with a resultant increase in plasma
osmolarity. As a result of an increase in osmolarity, fluid may
move out of the red blood cells, thus diminishing their size.
Put differently, events that change plasma osmolarity should
also change red cell volume, which discredits the use of only
hematocrit for estimating changes in plasma volume [36]. To
more accurately estimate changes in plasma volume, Costill
and colleagues [37–39] showed that such estimations should
incorporate both hematocrit and hemoglobin. Dill and Costill
[39] developed an equation that has been widely used for
estimating plasma volume shifts from changes in both
hematocrit and hemoglobin values:
BV2 ¼ BV1ð Þ Hgb1=Hgb2ð Þ
CV2 ¼ BV2ð Þ Hct2=100ð Þ
PV2 ¼ BV2  CV2
ΔPV;% ¼ 100ð Þ PV2  PV1ð Þ=PV1
where BV = blood volume, CV = red cell volume, PV =
plasma volume, Hgb = hemoglobin, Hct = hematocrit,
b ca
45%
100%
Fig. 1 Plasma volume loss and stress-hemoconcentration. a Normal
whole blood. b Normal blood that has been centrifuged. Red blood cells
become packed at the bottom of the tube. Plasma and non-diffusible
blood components remain at the top of the tube. c Stress-
hemoconcentrated blood that has been centrifuged. The volume of red
blood cells remains constant, but plasma volume decreases with a
resultant increase in the concentration of non-diffusible blood components
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subscript 1 refers to baseline sample, subscript 2 refers to
stressor (mental or physical) sample, BV1 is taken as 100,
and PV1 is 100 – Hct1.
Given that the conditions employed by Costill and
colleagues were rather severe (i.e., maximal exercise and
severe dehydration), Greenleaf et al. [36] examined whether
the addition of hemoglobin was indeed necessary to
estimate plasma volume shifts resulting from less extreme
conditions. Under conditions causing modest changes in
plasma osmolarity (i.e., short-term heat exposure and
orthostasis), hematocrit by itself estimated plasma volume
changes as well as those made from the Dill and Costill
[39] equation. That is, the change in the size of red blood
cells was not significant [36]. Furthermore, Patterson and
colleagues [40] found that, while plasma volume decreased
during acute psychological stress (mental arithmetic), no
changes were observed for red blood cell size (mean
corpuscular volume) during the same stressor. Although
the result of these studies suggest that hematocrit alone may
be suitable for assessing hemoconcentration, researchers
examining stress-hemoconcentration effects continue to use
the Dill and Costill equation to ensure the most accurate
approximations of plasma volume shifts by accounting for
possible variations in red cell sizes and fluid volume.
Hemoconcentration and Coronary Heart Disease
It is valuable to examine factors that influence hemocon-
centration given the close relationship between hemocon-
centration and blood pressure and given that hematocrit
seems to be an independent risk factor for all-cause
mortality, CHD, and hypertension [41–45]. For example,
logistic regression analyses suggest that hematocrit explains
up to 13% of the variance in CHD incidence [42] and 10%
of the variance in blood pressure in those with and without
hypertension [45] beyond that associated with traditional
risk factors (e.g., overweight, diabetes, and smoking).
Several epidemiological studies have indicated that
hematocrit is predictive of CHD. For example, in the
Puerto Rico Heart Health Program [41, 42], hematocrit at
baseline in middle-aged men was related to all-cause
mortality over 8 years. However, hematocrit was related
to the incidence of myocardial infarction or death from
acute coronary events only among urban dwellers, but not
among rural inhabitants. Specifically, after adjustment for
coexisting risk factors, an urban man with a hematocrit of
50% would have had a 50% higher chance of an incident
coronary event during the 8-year follow-up than an urban
man with a hematocrit of 40%. The authors speculated that
this relationship was not observed in rural individuals
because a smaller relative sample was used (2,369 rural vs.
5,720 urban residents; 42). Nevertheless, the possibility that
cultural variations accounted for the observed effects
cannot be eliminated entirely by low statistical power.
More recently, Kunnas and associates [46] compared the
risks for CHD events among Finnish men with hematocrit
greater than or equal to 50 to men with hematocrit less than
50. Men with lower hematocrit had better survival rates
than those with higher hematocrit. Likewise, men with
hematocrit greater than 50 had a 1.8-fold increased risk of
death from CHD events compared to those with hematocrit
less than 50 [46]. Elevated hematocrit relative to normal
hematocrit probably puts an individual at a greater risk for
acute coronary syndromes and may exert its effects through
increased whole blood viscosity.
Epidemiological and laboratory studies also suggest that
elevated hematocrit and contracted plasma volume are
related to essential hypertension. For instance, in the
Gubbio Population Study [43], the resting hematocrit levels
were significantly higher in untreated hypertensive individ-
uals compared to normotensive individuals. Furthermore,
after adjustment for traditional risk factors, hematocrit
showed an independent association with systolic (SBP)
and diastolic (DBP) blood pressure. Several studies have
also shown a lower plasma volume to be related to essential
hypertension [47–49]. For example, the Men of 1913 Study
[47] found that 50-year-old men with DBP >100 mmHg
had significantly lower plasma volume at rest and during
and after exercise than men with DBP <100 mmHg. Such
differences, however, are not due to loss of extracellular
water. Hypertensive and normotensive individuals do not
have different amounts of extracellular fluid but rather have
an altered distribution of the components of extracellular
fluid. In other words, the ratio of intravascular fluid to
interstitial fluid is lower in hypertensive than in normoten-
sive individuals [50, 51]. Given that the total amount of
extracellular fluid is not different between hypertensive and
normotensive individuals, the reduction in this ratio cannot
be expected to result from greater renal filtration and
excretion of fluid. Instead plasma is displaced from the
intravascular to the interstitial space [51]. Furthermore, men
with severe [52] and early borderline [53] essential
hypertension have a stable red cell mass, indicating that
the increased hematocrit among those with essential
hypertension is likely due to a contracted plasma volume.
However, one must bear in mind that the direction of
causality between hypertension and hemoconcentration
state cannot be determined on the basis of such observa-
tional studies. Altogether, contracted plasma volume and
elevated hematocrit suggest that essential hypertension may
confer a chronic hemoconcentration state. Given that
hematocrit and plasma volume are related to CHD and
hypertension and that psychological stress has long been
purported to be involved in heart disease, it is not surprising
that hemoconcentration effects have been studied during
periods of stress.
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A large literature in blood rheology describes the process
by which blood flowing through the branches, bifurcations,
and curvature of the coronary arteries can lead to stable and
unstable atherosclerotic plaques and damage to the endo-
thelium of blood vessels. Researchers applying principles
of fluid dynamics to blood flow within arteries have
identified that, with increased cardiac output, the intensity
of both low- and high-pressure areas on certain parts of the
artery surface also increases such that, at predictable areas
of intensified low pressure, endothelial cells may lift from
the intima, sometimes resulting in shearing endothelial cells
from the vessel wall (see Figs. 2 and 3). The force created is
a tensile force, in effect a suction action, stimulating the
intima to proliferate and to actually become an atheroscle-
rotic plaque. Consequently, damage to the endothelial cells
in the low-pressure sites, or eddies, exposes the underlying
tunica media, therefore producing intense vascular inflam-
mation, progressive lipid accumulation, and formation and
expansion of a necrotic core [54–57]. Interestingly,
epidemiological research has shown that the increase in
blood viscosity and volume is associated with various
types of cardiovascular disease and may prove to be an
important link between psychological stress and heart
disease in future research. Blood and plasma viscosity
and flow rate play a major role in facilitating the low
pressure at these sites [56, 58]. Thus, it is conceivable that
stress-mediated increases in blood viscosity could further
decrease the pressure at the bifurcations, branches, and
curvature of the coronary arteries and increase the
exposure time of hemoconcentrated atherogenic substan-
ces (i.e., lipids, platelets, and macrophages) to the
atherosclerotic lesion. Furthermore, increased blood vis-
cosity is related in part to elevated hematocrit and higher
fibrinogen concentrations also due to hemoconcentration
effects.
Hemoconcentration and Psychological Stress
Physiologists in several early studies examining hemocon-
centration effects subjected volunteers to various physical
stressors such as heat exposure [38, 59, 60], exercise [60],
altitude change [36, 61], prolonged bed rest [62], water
immersion [63], and head tilt [64]. Plasma volume
decreased relative to baseline across all of these stressors.
As such, these studies set the stage for the study of
hemoconcentration effects resulting from acute psycholog-
ical stressors as well as physiological challenges such as
posture change. Though orthostatic stress results in hemo-
concentration and hemostasis changes, the focus of this
review is on acute psychological stress. However, ortho-
static challenge is important in its own right and has
recently been reviewed [65].
Laboratory-induced psychological stress reliably
increases the various indices of hemoconcentration (i.e.,
hematocrit, hemoglobin, blood viscosity, and total plasma
protein concentration), presumably due to a reduction of
plasma volume. During acute mental stress, the concentra-
tion of large molecules (i.e., > 69 kDa) changes concurrent
with plasma volume shifts. Total plasma proteins, immune
cells, lipids, platelets, and many coagulation factors greatly
exceed 69 kDa (see Table 1). It is clear that these non-
diffusible blood constituents, perhaps with the exception of
coagulation factors, become hemoconcentrated during acute
mental stress (see Fig. 1). With regard to coagulation factors,
it is not entirely clear whether acute mental stress causes
enhanced coagulation activation through a greater concentra-
tion of the factors through stress-hemoconcentration or
through actual activation of the coagulation system. The next
section reviews previous work examining plasma volume
shifts during stress and mechanisms underlying stress-
hemoconcentration.
High viscosity–low pressure eddy site 
Fig. 2 Flow patterns found at artery bifurcations where blood flow is
low and blood viscosity is very high
Arterial wall
closest to
the
myocardium
Arterial wall
furthest from
the
myocardium
Atherosclerotic
plaque formation
Fig. 3 Flow patterns found along the coronary arteries that follow the
curved contour of the heart. Note that vessel wall shear stress and
blood flow are lowest and viscosity is highest along the inner arterial
wall closest to the heart
ann. behav. med. (2011) 42:153–173 157
D
ow
nloaded from
 https://academ
ic.oup.com
/abm
/article-abstract/42/2/153/4569544 by guest on 25 February 2020
Stress-Induced Changes in Indices of Hemoconcentration
Changes in various indices of hemoconcentration have been
examined after subjecting participants to acute psycholog-
ical stress. For instance, Jern and colleagues [66] investi-
gated the hematological and cardiovascular effects of
exposure to 10 min of mental arithmetic and subsequent
recovery in healthy young males. Along with increases in
heart rate, SBP, and DBP, significant increases in hemato-
crit and hemoglobin relative to a pre-stress baseline period
were observed during the mental arithmetic task. The mean
increases in hematocrit and hemoglobin were 0.8% and 3 g/
l, respectively. Moreover, both hematocrit and hemoglobin
changes in response to mental arithmetic were significantly
correlated with heart rate change. However, the correlations
between DBP and SBP with hematocrit and hemoglobin
were not significant. In an extension of this study, Jern,
Jern, and Wadenvik [67] examined the basal hematological
levels in young type A and type B males and females and
the effects of a 10-min mental arithmetic task on hemato-
logical and cardiovascular measures. Type A individuals
had significantly higher basal hematocrit (43.8% vs. 42.1%)
and hemoglobin levels (150 vs. 147 g/l) than type B
individuals. Hematocrit and hemoglobin increased signifi-
cantly during the stressor with magnitudes similar to that
reported by Jern et al. [66], but no type A/B differences
were observed in the magnitude of change. In both of these
studies, hematocrit and hemoglobin returned to baseline
levels after the mental arithmetic activity during a 10-min
recovery period. This quick return to baseline levels implies
that the hemoconcentration was due to reversible shifts in
plasma volume.
Similar findings have been observed with other stressors
and with additional measures of hemoconcentration. For
example, compared to individuals resting quietly, the total
plasma protein concentration increased significantly in
individuals completing the Stroop Color–Word Interference
Test and orthostatic challenge, but correcting for plasma
volume changes rendered these effects non-significant [68].
Furthermore, an index of cardiovascular “reactivity” (resi-
dualized heart rate and blood pressure change scores were
standardized and summed) was positively correlated with
stress-induced changes in total cholesterol level and
hematocrit [67]. In a similar study [32], plasma volume,
plasma viscosity, total plasma proteins, blood pressure, and
heart rate were assessed in healthy, young men during a 30-
min rest period and a 5-min speech stressor. Plasma volume
decreased significantly during the stressor, which corre-
sponded to an increase in plasma viscosity and in total
plasma protein concentration. In addition, a change in
plasma volume from baseline to stress had a significant,
negative correlation with changes in heart rate and SBP.
Similar relationships between hemoconcentration and he-
modynamic measures were reported by Veldhuijzen van
Zanten and associates [69–71]. On the other hand, Bacon
and colleagues [28] found no relationship between blood
pressure changes and stress-induced hemoconcentration in
patients with CHD and suggested that this may be due to
the likely relatively poorer endothelial function of diseased
patients. Altogether, with the exception of a few studies
[28, 66, 67], these lines of evidence suggest that, in healthy
individuals, increased hydrostatic pressure from sympathetic-
induced cardiovascular responses to stress is responsible for
the movement of fluid into extravascular spaces and the
Clotting factor Synonyms Molecular weight
(kDa)
Fibrinogen Factor I 340
Prothrombin Factor II 71.6
Tissue factor Factor III; tissue thromboplastin 44
Calcium Factor IV 40
Factor V Proaccelerin; labile factor; Ac-globulin 330
Factor VII Serum prothrombin conversion accelerator;
proconvertin; stable factor
50
Factor VIII Antihemophilic factor; antihemophilic globulin;
antihemophilic factor A
330
Factor IX Plasma thromboplastin component; Christmas
factor; antihemophilic factor B
57
Factor X Stuart factor; Stuart-Prower factor 58.8
Factor XI Plasma thromboplastin antecedent; antihemophilic
factor C
143
Factor XII Hageman factor 78
Factor XIII Fibrin-stabilizing factor 320
High molecular weight
kininogen
Fletcher factor 88–120
Table 1 Clotting factors in
blood
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consequent concentration of non-diffusible blood components
[32, 68].
The reason why Jern and colleagues [66, 67] did not find
a relationship between blood pressure changes and hemat-
ocrit changes is not entirely clear, although low power due
to small sample sizes is one possibility. Alternatively,
changes in various substances known to alter vascular
permeability (e.g., atrial natriuretic peptide, histamine,
norepinephrine, and tryptase) could provide another avenue
for stress-hemoconcentration and perhaps could mediate
stress-hemoconcentration [70]. However, no relationship
was found when examining changes in tryptase as a
possible mechanism of stress-hemoconcentration [70].
Nevertheless, other substances that regulate vascular per-
meability may play a role in stress-hemoconcentration and
should be examined in the future.
Although these studies strongly suggest that hemocon-
centration occurs relatively quickly during acute stress, they
did not address how long it takes for a hemoconcentration
state to return to normal (i.e., recovery time). Patterson and
colleagues [40] reported the hemoconcentration effects for
total plasma proteins among healthy males and females
completing a 10-min stressful serial subtraction task with
harassment compared to control individuals completing a
benign reading task. Calculated plasma volume and mean
arterial pressure (MAP) were measured every 2 min during
the mental arithmetic task and every 3 min during the 30-
min recovery period. The percent change in plasma volume
relative to baseline was negatively correlated with MAP
across the mental arithmetic task and recovery period.
Moreover, the percent change in plasma volume remained
depressed and MAP remained elevated during the first
9 min of the recovery period, but both returned to baseline
levels after 12 min of recovery. It was concluded that stress-
induced changes in plasma volume and blood pressure
return to normal within 12 min and these changes coincide
during the stress task and recovery period. Thus, further
support was provided for the notion that blood pressure
elevations are the driving force behind plasma volume
losses during stress and subsequent hemoconcentration of
non-diffusable blood components. However, as Patterson
and associates [40] acknowledged, increased renal function
and diuresis following stress could account for plasma
volume losses. Along the same lines, Muldoon and
colleagues [72] reported that, in healthy male participants,
plasma volume remained lower than baseline levels after a
30-min recovery period following mental arithmetic and a
Stroop task; thus, it was suggested that increased renal
filtration could be responsible for prolonged plasma
volume losses. However, blood pressure and plasma
volume were only measured at the end of the recovery
period, so one cannot rule out the possibility that they
corresponded inversely throughout the recovery period. It
is also possible that plasma volume losses are driven by a
combination of increased blood pressure, increased renal
filtration, and changes in substances regulating vascular
permeability.
de Boer and colleagues [9, 29, 73] further examined the
time course and mechanisms of hemoconcentration in
response to mental stress as well as the relationships
between hematological and cardiovascular variables. In
the first study [73], male participants completed a 4-min
paced auditory serial addition test and were led to believe
that their performance would be analyzed for body and
facial composure during the task. Hematocrit increased
gradually during the first 3 min of mental stress, plateauing
in the fourth minute. Hematocrit was at its highest level in
the first minute of recovery and steadily decreased back to
baseline levels within 16 min of the recovery period, which
is somewhat similar to 12 min following a 10-min math
stressor in the Patterson et al. [40] study. Therefore, the
recovery time may be relatively independent of the length
of the stress task, at least in the case of math stressors (i.e.,
serial subtraction and paced auditory serial addition test)
lasting up to 10 min. However, it is possible that recovery
slows down with stressors of longer duration or of different
types. Such a possibility is supported by the findings of a
study in which hematocrit failed to return to baseline levels
30 min after a 20-min combined Stroop–mental arithmetic
task [72]. Furthermore, within-subjects correlations be-
tween hemodynamic variables and hematocrit from base-
line through recovery were significant [73], which is
consistent with between-subjects observations seen in
previous studies [8, 32], providing more support for the
notion that blood pressure changes underlie hemoconcen-
tration during stress. Alternatively, subsequent studies [9,
29] suggest that hematocrit recovery after the termination of
a stressor may be independent of blood pressure changes
and may rely more on intravascular colloid osmotic
pressure to draw plasma back into the vascular compart-
ment, therefore suggesting that greater colloid osmotic
pressure produces quicker post-stress plasma volume
recovery.
The aforementioned studies have all included normoten-
sive individuals as participants, but a number of studies
have assessed hemoconcentration and hemodynamic stress
responses in hypertensive patients. For instance, Kitahara
and colleagues [74] studied men and women with mild
hypertension who underwent a 10-min period of speech and
mental arithmetic followed by a 60-min recovery period.
The mental stress period resulted in a significant increase of
hematocrit (0.7%) and hemoglobin (2 g/l), which returned
to baseline levels during the recovery period. Parallel
increases in blood pressure and heart rate were observed
during the stressor, with significant positive correlations
between hematocrit change and both SBP change and heart
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rate change. Sakamoto, Imataka, Nishimura, and Fujii [75]
conducted a very similar study utilizing the same stressor as
well as isometric handgrip exercise and found comparable
increases in hematocrit (0.5% for both tasks) and blood
pressure.
Stress-hemoconcentration effects reliably occur during a
variety of mental stressors, whether it is observed as
changes in hematocrit, hemoglobin, total plasma protein
concentration, or plasma volume. Stress-hemoconcentration
is observed in men and women, normotensive and
hypertensive individuals, and people of different age
groups. A large amount of evidence indicates that tasks
producing sympathetic nervous system activation result in
the largest increases in hematocrit and hemoglobin and that
these changes are likely produced by increases in blood
pressure and heart rate.
As previously discussed, blood viscosity increases when
stress-hemoconcentration occurs. Psychologically stressful
events could precipitate acute coronary syndromes through
this mechanism. The disruption of normal blood rheology is
probably most important in areas of the vasculature where a
vulnerable plaque is already present or in areas of low
blood flow [7]. Where a plaque is already present, the
plaque itself increases local shear stress and viscosity by
reducing the vessel’s diameter. An even greater increase in
viscosity could precipitate plaque fissuring and thrombus
formation [76]. In areas of low blood flow, increased
viscosity could further decrease pressure and increase the
amount of time that concentrated blood components (e.g.,
lipids, platelets, clotting factors) have contact with the
endothelium. In turn, endothelial cells could be lifted from
the intima, affording a greater opportunity for the aggrega-
tion of platelets and subsequent thrombus formation [7, 76].
In addition to elevated blood viscosity, stress-
hemoconcentration is accompanied by hypercoagulation
[18]. Moreover, hypercoagulation may be a mechanism of
acute coronary syndromes initiated by acute psychological
stress [10, 11]. Therefore, the remainder of this review
describes hemostasis physiology and links between hemo-
stasis and heart disease as well as provides an update on the
research examining coagulation and platelet changes during
acute stress. Finally, links between coagulation and stress-
hemoconcentration are discussed.
Hemostasis
Hemostasis is a critical defense mechanism against bleed-
ing whereby blood loss is prevented after a vessel is
damaged [20]. Theorists have long associated psychologi-
cal stress with accelerated hemostasis and thickening of the
blood. Given that hemostasis factors are of primary
importance to this review article, hemostasis will be
described in detail. Particular emphasis is placed on
coagulation factors, leading to the central question
addressed here—whether the apparent increase in coagula-
tion activity during acute psychological stress is due to the
actual activation of the coagulation system or as a result of
hemoconcentration, or a combination of both.
Hemostasis Physiology
Hemostasis is a complex process that stops bleeding, often
changing blood from a fluid to solid state. The process of
hemostasis is achieved by three fundamental processes—
vascular spasm, platelet plugging, and coagulation [20, 77].
Figure 4 provides a schematized view of hemostasis.
Vascular Spasm
First, a vascular spasm occurs to minimize the immediate
loss of blood. The vessel walls contract immediately after a
blood vessel suffers a trauma to minimize the amount of
blood leaving the vessel. The vascular spasm can last for
minutes to hours, during which time the other two
mechanisms for halting blood loss occur (i.e., platelet
plugging and blood coagulation).
Platelets
Platelets are minute, round or oval anuclear cells that serve
several hemostatic functions. They are activated either
when stimulated by various agonists or when contacting a
foreign surface or the subendothelial collagen of a damaged
vessel wall. Once activated, they have granules that move
to the platelet surface and release their contents into the
plasma. Two types of granules are of primary concern to
hemostasis: alpha granules and dense bodies. The alpha
granules contain many important substances involved in
thrombosis and atherosclerosis, including fibrinogen, plate-
let factor 4 (PF4), beta-thromboglobulin (BTG), Factor V,
Factor VIII, von Willebrand factor, and platelet-derived
growth factor [78, 79]. Substances released from platelet
granules, especially thromboxane B2 (a metabolite of
thromboxane A2), PF4, and BTG, are often measured as
markers of platelet activation [5, 6, 80]. Dense bodies hold
adenosine diphosphate, calcium ions, and thromboxane A2,
all of which activate other platelets.
Once activated, the platelets undergo drastic changes to
carry out the following functions: (1) formation of a platelet
plug to occlude sites of vascular damage, (2) provide a
surface for the configuration and activity of coagulation
proteins, (3) serve as the nucleus around which a fibrin clot
forms, and (4) secrete various factors involved in vascular
repair [78]. When activated, platelets swell, assume
irregular forms, become sticky, and activate other platelets.
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The stickiness of platelets causes them to adhere to each
other. This process continues, attracting more and more
platelets to the newly forming platelet plug. At first, the
platelet plug is loose, but it sufficiently blocks blood loss if
damage to the vascular wall is minor. If a rupture is very
small, it is often sealed only by a platelet plug. Minute
ruptures occur in very small blood vessels hundreds of
times daily. Thus, the formation of the platelet plug is
extremely important for closing these minute ruptures. If
the rupture is severe, however, then platelets stimulate
blood coagulation, the third step in hemostasis, through the
release of activator substances [20, 77]. Another response
of platelet activation is the expression of receptors for
coagulation factors [79]. Coagulation factors, in turn, bind
to and stimulate platelets in a positive feedback fashion to
form the final hemostatic plug [78].
Blood Coagulation
Blood coagulation is the formation of a blood clot in a
damaged vessel or through inappropriate activation such as
during thrombus development. More than 50 substances
affect coagulation. Whether or not blood will coagulate
depends on the balance between anticoagulants and
procoagulants. In normal states, anticoagulants predominate
and clots do not develop [81]. However, after a vessel
ruptures, procoagulants become “activated” and override
anticoagulants, resulting in the development of a blood clot.
Rapid clotting in such situations or during pain or
psychological stress is adaptive because it prevents fatal
bleeding from occurring [82].
Coagulation takes place in three essential steps: forma-
tion of prothrombin activator, conversion of prothrombin to
thrombin, and formation of a clot through the conversion of
fibrinogen to fibrin [20]. These steps were described by two
independent laboratories as a cascade [83] and a waterfall
[84] in which the activation of one clotting factor leads to
the activation of another, culminating in a burst of thrombin
generation that catalyzes the conversion of fibrinogen to
fibrin. Although these two groups labeled coagulation
differently, they both described the same basic model.
Eventually, the waterfall label was abandoned but the
cascade term has persisted. In this model, the clotting
factors are proenzymes (i.e., inactive precursors of
enzymes) that are available to be converted to active
enzymes. This model further suggests that clotting can be
initiated by either the extrinsic or intrinsic pathway, each of
which ultimately leads to a common pathway. The extrinsic
and intrinsic pathways correspond to the first step of
coagulation—the formation of prothrombin activator. At
the end of this step, the two pathways merge into a common
pathway. Once the prothrombin activator is formed, it
converts prothrombin to thrombin. Thrombin must then be
present to convert fibrinogen to fibrin so that a clot can
form [20]. The extrinsic pathway, intrinsic pathway, and
common pathway are described in detail (Fig. 5).
Extrinsic Pathway The extrinsic pathway is initiated by
tissue damage, which triggers the release of a complex of
factors (i.e., tissue factor) released into the blood by
damaged tissue. Two important parts of this complex are
phospholipids from the cell membranes of the tissues and a
lipoprotein complex that contains a critical enzyme. Once
tissue factor is released, the lipoprotein complex acts
enzymatically on Factor VII (FVII), resulting in activated
Factor VII (FVIIa). FVIIa, in the presence of calcium, acts
on Factor X (FX) to form FXa. FXa combines with the
phospholipids of tissue factor and with FVa to form
Fibrin
Clot
Endothelium
Von Willebrand Factor
Platelets
Coagulation
FV FXI
FVII FXII
FVIII Calcium
FIX Fibrinogen
FX Thrombin
FibrinolysisFibrin degradation
products (e.g. D-dimer)
+ +
-+
Fig. 4 Overview of hemostasis
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prothrombin activator [20, 77, 81]. Clotting via the
extrinsic pathway is fast, taking as little as 15 s [81].
Table 1 contains a list of clotting factors, their synonyms
and molecular weights.
Intrinsic Pathway The intrinsic pathway is so named because
all of its components are present in the blood. The intrinsic
pathway is most likely implicated in CHD because CHD
develops inside the vasculature. It is initiated by blood contact
with a damaged interior vessel surface, which activates
platelets. When platelets become activated, they release
phospholipids and their membranes become negatively
charged. Factor XII (FXII) is a plasma protein that becomes
activated (FXIIa) when coming into contact with a negatively
charged surface such as a glass test tube or the membrane of an
activated platelet. Subsequently, FXIIa acts on FXI, resulting
in FXIa. FXIa acts enzymatically on FIX, resulting in FIXa.
FIXa acts in concert with FVIIIa to activate FX, resulting in
FXa. FXa combines immediately with platelet phospholipids
and FVa to form prothrombin activator [20, 77, 81]. Clotting
via the intrinsic pathway is much slower than via the
extrinsic pathway and takes 1 to 6 min [20].
Final Common Pathway After prothrombin activator is
formed by the extrinsic or intrinsic pathway, it catalyzes the
conversion of prothrombin to thrombin. In addition,
platelets play an important role in the conversion of
prothrombin to thrombin. Much prothrombin first attaches
to prothrombin receptors on platelets bound to a damaged
tissue. This binding, in turn, accelerates the formation of
thrombin from prothrombin at the exact location where a
clot is needed. Subsequently, thrombin has a number of
important physiological functions. First, it activates plate-
lets to help in the formation of a platelet plug. Second, it
acts in a positive feedback fashion on the coagulation
system by increasing the activation of FV and FVIII.
Finally, it is essential for the conversion of fibrinogen to
fibrin, the last step of the coagulation cascade [20].
Within 10–15 s of its formation, thrombin acts enzymat-
ically to convert fibrinogen to fibrin monomers. Fibrin
monomers have the automatic capability of joining together
to form long fibrin fibers. These fibrin fibers then enmesh
platelets, blood cells, and plasma to form a clot. Addition-
ally, fibrin fibers adhere to damaged surfaces of blood
vessels. Thus, the blood clot adheres to any vascular
opening, thereby preventing blood loss [20].
Fibrinolysis
Once a clot has started to develop, it normally expands into
the surrounding blood within minutes [20]. The clot
initiates a vicious cycle (i.e., positive feedback) to promote
more clotting by stimulating platelets as well as parts of the
clotting cascade itself. The blood clot continues to grow
until something stops its growth. Termination of clot
growth is accomplished by the plasma protein system
known as the fibrinolytic system. The process of fibrino-
lysis works to prevent the vasculature from becoming one
uncontrolled, continuous clot. The main function of the
fibrinolytic system is the removal of minute clots from the
millions of tiny peripheral vessels that would eventually
become occluded were there no way to break down and
clear them. However, the fibrinolytic system also clears
larger clots that occur with severe vessel damage, such as
those occurring from lacerations [20, 85]. In the long run,
the components of the fibrinolytic system interact with the
coagulation system to keep the blood from becoming either
too thick or too thin.
Fig. 5 The scheme depicts coagulation pathways in solid lines and
fibrinolysis pathways in dashed lines. Anticoagulant steps are drawn
in dash-dotted lines. Roman numerals indicate coagulation factors.
The prethrombotic markers of a hypercoagulable state are depicted in
boxes. a2-AP a2-antiplasmin, AT III 5 antithrombin III, DD fibrin D-
dimer, F112 prothrombin fragments 112, FDP 5 fibrinogen/fibrin
degradation products, FPA fibrinopeptide A, PAP plasmin-a2-
antiplasmin complex, t-PA tissue plasminogen activator, PAI-1 type 1
plasminogen activator inhibitor, vWF von Willebrand factor, TAT
thrombin-antithrombin III complex. The symbol “┴” indicates the
inhibition steps of thrombin, plasmin, and t-PA. Adapted with
permission from “Effects of psychological stress and psychiatric
disorders on blood coagulation: A biobehavioral pathway to coronary
artery disease?” by R. von Känel et al. [10], p. 32 (copyright 2001 by
Wolters Kluwer Health)
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Other Factors Involved in Hemostasis
Numerous other physiological factors are involved in
hemostasis. Plasma D-dimer is a molecular marker of
hemostatic activation [85] whose level reflects fibrin
turnover both from intravascular fibrin formation and from
consequent fibrinolysis. As opposed to other hemostatic
markers, D-dimer is more easily detected in plasma because
of its comparatively longer half-life and because it is a
marker of activation of both the coagulation and fibrinoly-
sis systems [86]. Thus, it is likely a reliable indicator of in
vivo activation of the hemostatic system [87].
von Willebrand Factor (vWF) is a very large molecule
released from stimulated or damaged endothelial cells.
Thus, the plasma level of vWF indicates endothelial cell
dysfunction. Once released into the circulation, vWF
plays an essential role in hemostasis by triggering
platelet adhesion to places of vascular injury in areas of
high shear stress (e.g., in arterioles and microcirculation)
and the aggregation of platelets to each other. Further-
more, vWF indirectly influences the coagulation cascade
by acting as the carrier protein for FVIII in the plasma
[78, 88].
Cell-Based Model of Hemostasis
It should be noted that many researchers have adopted a
cell-based model of coagulation in favor of the cascade
model because the coagulation model has shortcomings as a
model of the hemostatic process in vivo [89–91]. In this
model, procoagulant forces are restricted to the site of
vessel damage rather than extending throughout the
vasculature. Such control of coagulation is achieved by
localizing the procoagulant reactions at the site of injury on
specific cell surfaces, particularly platelets and tissue factor-
bearing cells. These two types of cell interact to either
inhibit or accelerate clotting [89]. However, the existing
clotting assays used to assess tissue factor activity lack
sensitivity and specificity [92]. Moreover, an examination
of acute clotting changes in vivo such as those occurring
during acute psychological stress is challenging. Therefore,
research has been restricted to changes measured in vitro
within the scope of the cascade model.
Hemostasis and Cardiovascular Disease
A very large number of studies have examined the links
between various aspects of hemostasis to cardiovascular
disease. A detailed examination of this research is beyond
the scope of this review. Therefore, this section only
provides a brief overview of research examining the
relationships between platelets and coagulation factors and
CHD and hypertension.
Platelets and Coronary Heart Disease
Platelets play an important role in the development of
CHD. Their importance is emphasized by the effectiveness
of aspirin, a platelet aggregation inhibitor, in reducing the
incidence of myocardial infarction [93]. Regarding patho-
physiology, platelet-derived growth factor causes smooth
muscle cells to grow and migrate into the intima of arteries.
Smooth muscle is a primary component of mature
atherosclerotic plaques [94]. Furthermore, the platelets
themselves bind to foam cells that are exposed when the
endothelium becomes damaged in the initial stages of
plaque formation. When platelets adhere to exposed
endothelium at the site of a lesion, they increase the size
of the lesion and capture leukocytes on the lesion surface,
forming platelet–leukocyte aggregates (PLAs; [95]). Platelet–
leukocyte binding additionally promotes several processes
involved in inflammation and thrombosis, such as fibrin
formation and deposition within a developing thrombus [96].
These processes occur at the beginning of atherosclerotic
development, but platelet function is also intimately involved
in the later stages of CHD, such as in acute coronary
syndromes. At points of increased wall shear stress, plaques
are more likely to fissure and rupture. It is at these sites to
which platelets adhere, followed by subsequent platelet
activation. Once activated, platelets release various substan-
ces involved in vessel occlusion and play a central role in the
formation of arterial thrombi. After adhering to a site of
rupture, they release thrombin and platelet agonists, such as
adenosine diphosphate, serotonin, and thromboxane A2,
leading to further platelet recruitment, activation, and
aggregation [96].
Further showing the importance of platelets in CHD are
epidemiologic studies showing the increased levels of
platelet markers (i.e., BTG and PF4) and PLAs in patients
with acute coronary syndromes, unstable angina, and stable
CHD (for reviews, see [5, 92]). In the vast majority of
studies, platelet markers and PLAs have a positive
relationship with CHD. Moreover, patients with stable
CHD have elevated levels of circulating activated platelets
and have platelets that are more reactive to platelet agonists
compared to healthy controls [97].
Blood Coagulation and Coronary Heart Disease
Many coagulation factors have been associated with
hypertension and CHD. Of these, fibrinogen and D-dimer
are probably the strongest risk markers, although other
hemostasis variables (e.g., FVII, FVIII, and vWF) have
independently predicted CHD in some [98–102] but not in
all studies [12, 103, 104]. Hypercoagulability likely spurs
the chronic development of CHD by providing an environ-
ment for gradual deposition of fibrin within atherosclerotic
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plaques [105]. Notwithstanding the long-term unfavorable
effects on the vasculature, a procoagulant environment also
plays a central role in CHD by speeding thrombus
enlargement after plaque disruption [106]. Thus, if periods
of acute psychological stress stimulate hypercoagulability,
then it is plausible that such stressful events could
precipitate the initiation of CHD [10].
Hemostasis and Acute Psychological Stress
Platelets and Stress
It has long been known that catecholamines (i.e., norepi-
nephrine and epinephrine) are strong stimuli for platelet
activation in vitro [107–109] and that platelets contain
alpha2-adrenergic receptors [110]. Individuals with various
psychological disorders, including general anxiety disorder,
panic disorder, and posttraumatic stress disorder, have
fewer platelet alpha2-adrenergic receptors available for
binding (i.e., catecholamines are already bound to a large
number of receptors), which is consistent with the greater
catecholamine concentrations also seen in these conditions
[111]. Emotional stress stimulates the sympathetic nervous
system, which in turn causes the release of catecholamines
[111, 112] that have the potential to activate platelets.
Table 2 in the “Electronic Supplementary Material”
summarizes a large body of research, which suggests that
acute psychological stress is related to changes in platelet
activity in individuals with and without cardiovascular
disease. Platelet aggregability appears to increase immedi-
ately after acute psychological stress [113–116]. Addition-
ally, many studies report increases in the levels of the
platelet activation markers circulating platelet factor 4
(PF4) and beta-thromboglobulin (BTG) among healthy
individuals [6, 116–121] and among individuals with
essential hypertension [122] and with angina pectoris
[123]. However, not all studies have reported significant
changes in platelet aggregability [124–126] and platelet
activation markers [123, 127, 128] in response to acute
stress. For example, Wallén and colleagues [123] reported
that acute stress did not elicit elevations in these platelet
activation markers in elderly healthy volunteers. They
speculated that the balance between platelet activation and
inhibiting systems during tasks that elicit acute stress may
be different in elderly than in younger individuals.
Alternatively, there may be more variation in artefactual
platelet activation resulting from older methods of assessing
platelet function [129].
Although platelet activation markers generally increase
during acute psychological stress in both groups, hyperten-
sive individuals have larger or prolonged responses of these
markers than healthy, normotensive individuals. For in-
stance, platelet activation following epinephrine infusion is
greater in hypertensive individuals than in normotensive
individuals [130]. Similarly, Tomoda and colleagues [122]
reported that the BTG response is dependent on the
hypertensive status. Normotensive individuals did not have
BTG changes during a mental arithmetic stressor, whereas
individuals with World Health Organization [131] stage 1
(SBP 140–159 or DBP 90–99) and stage 2 (SBP 160–179
or DBP 100–109) hypertension had significant BTG
increases. Individuals with stage 1 hypertension had greater
increases during mental arithmetic than individuals with
stage 2 hypertension, which is most likely due to platelet
function already being enhanced in the resting period
among those with stage 2. The temporary increase in
platelet function during stress in the early phase of
hypertension (i.e., stage 1) could bring about a perpetual
enhancement of platelet function in the more advanced
phase of hypertension (i.e., stage 2; 122). Furthermore,
epinephrine infusion in vivo may cause greater platelet
activation and aggregation, and platelets from hypertensive
men appear to be even more responsive to epinephrine
compared to platelets from normotensive men (for a review,
see [132]).
The findings are less consistent when examining stress-
induced changes in platelet activation markers in CHD
patients. Bacon and colleagues [133] reported that PF4 did
not change following the paced auditory serial addition test,
similar to Wallén et al. [123]. In another study [120], BTG
levels increased significantly following a structured inter-
view and speech task in the control group, but not in post-
infarction patients. Similarly, Reid et al. [128] found no
change in BTG in CHD patients following a stressor
protocol that included mental arithmetic and anger recall.
Conversely, Wallén et al. [123] found that BTG levels
increased significantly following a Stroop task among
angina patients. It is unclear why these dissimilar results
occurred, but the differences in stressor intensity or disease
severity may have played a role.
A few studies have assessed PLA responses to acute
stress. However, the results from such studies are more
consistent than those of studies examining stress-induced
changes in platelet activation markers. Moreover, the
measurement of circulating PLAs via flow cytometry may
provide a more sensitive marker of in vivo platelet
activation [96]. One study [134] examined PLA responses
to a color/word interference task and mirror tracing task in
healthy, middle-aged men. Total circulating PLAs, as well
as three sub-populations of aggregates (platelet–monocyte,
platelet–neutrophil, and platelet–lymphocyte aggregates),
increased significantly after the behavioral stressors. How-
ever, the peak increase in PLA levels was observed 30 min
post-stress as opposed to immediately after the tasks,
indicating that PLA responses are delayed in comparison
to blood pressure and heart rate reactivity. Nevertheless,
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total PLAs and platelet–monocyte aggregates were posi-
tively related to SBP changes immediately after stress,
implicating the sympathetic nervous system, at least in part,
in the PLA response to acute stress [134]. Two studies have
been published that examined stress-induced PLA changes
in patients with CHD [17, 128]. Both studies reported that
PLAs increased after acute stressors. However, Reid et al.
did not include a control group and did not examine
recovery. On the other hand, Strike and colleagues
compared the PLA response to a color/word interference
task and mirror tracing in male patients with established
CHD to the PLA response in healthy, age-matched controls.
Although there were no differences between the two groups
in PLAs at baseline and the increases in PLAs during stress,
PLAs remained elevated for an extended period of time
(75 min) in the patients with CHD but, similar to Steptoe et
al. [134], PLAs returned to baseline levels in the controls.
Therefore, the prolonged elevation of PLAs provides one
mechanism through which patients with CHD may be
vulnerable to acute coronary syndromes in the 1–2 h
immediately after acute stress. Still, one must use caution in
interpreting the results from observational studies using
CHD patients and non-patients because it is impossible to
tease apart whether changes in response to acute stress in
patients precede and cause their disease state or are a
consequence of it.
A major limitation in the vast majority of platelet stress
reactivity studies is that adjustments for stress-
hemoconcentration have generally not been conducted.
One exception [121] suggests that the effects of acute
stress on PF4 and BTG levels are independent of
hemoconcentration. That is, elevations in PF4 and BTG
survived mathematical correction for plasma volume shifts.
Rather, changes in platelet activation are most likely related
to increased catecholamine secretion [119, 121]. Along
these lines, the adrenergic binding sites on platelets undergo
changes and may become desensitized or have increased
density following acute psychological stress [135, 136],
suggesting catecholamine surge and, subsequently, greater
platelet activation. Moreover, although the overall levels of
PLAs and platelet-monocyte aggregates decreased across
two sessions at 4 weeks apart, the platelet response to acute
psychological stress appears to be resistant to habituation
[137, 138]. That is, the platelet activation response to acute
stress did not decrease over 4 weeks. Altogether, platelets
seem to become more active during psychological stress
and this response does not habituate. Over time, elevated
platelet activation resulting from acute stress could promote
processes involved in inflammation and thrombosis, pro-
viding one possible mechanism through which stress may
be linked to cardiovascular disease.
Activated platelets release activator substances that
initiate coagulation activity. Once the platelets become
activated, they also express receptors for coagulation
factors. Subsequently, coagulation factors bind to and
further stimulate platelets. Thus, platelet activation initiates
but also perpetuates clotting activity [20, 77–79]. If
psychological stress activates platelets, platelets may, in
turn, stimulate blood coagulation. The following section
reviews coagulation and its relationship to acute psycho-
logical stress.
Blood Coagulation and Acute Stress
As early as the 1910s, Cannon and Mendenhall [139]
showed that blood coagulation was accelerated in cats in
“fight–flight” circumstances, such as pain and emotional
excitement. Such conditions also increase adrenal secre-
tion. In addition, Cannon and Gray [140] showed that
injecting adrenalin (i.e., epinephrine) shortened clotting
time. Furthermore, Cannon and Mendenhall [82] reported
that adrenalin secretion from the adrenal glands as occurs
with splanchnic stimulation accelerated clotting. Taken
together, these early findings indicate that sympathetic
activity accelerates coagulation. Rapid clotting during pain
or emotional excitement is adaptive, defending the
organism against fatal bleeding that could occur during
an injury [82].
Cannon’s work set the stage for the next century of
research that examined the effects of emotion, stress, and
anxiety on coagulation as well as fibrinolysis. von Känel
and colleagues [10] reviewed this work and concluded that
both coagulation and fibrinolysis activities increase during
acute psychological stress but that coagulation increases to
a greater extent than fibrinolysis, resulting in net hyperco-
agulability. Moreover, a recent review by Thrall and
colleagues [11] reported that the findings of studies
examining the effects of acute psychological stress on
fibrinolysis have been inconclusive. For example, studies
have reported increases, no change, and decreases in tissue-
type plasminogen activator (t-PA), the molecule account-
able for degrading fibrin into soluble fragments [11]. This
inconsistency might partially be explained by the fact that
studies have variously investigated the activity or antigen
levels of t-PA [10]. This would be an important distinction
because, while the increased levels of t-PA activity mean
enhanced fibrinolysis, the elevated t-PA antigen levels
reflect reduced fibrinolysis as t-PA antigen indicates the
amount of active t-PA that has become inactivated in a
complex with plasminogen activator inhibitor-1. However,
an extended review of such studies is beyond the scope of
this paper. Therefore, only recent studies of the effects of
acute stress on coagulation are discussed here.
Investigations of the effects of acute psychological stress
on coagulation have generated generally positive findings
for markers of the intrinsic and extrinsic coagulation
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pathways as well as markers of the common pathway (see
Table 3 in the “Electronic Supplementary Material”). Such
findings are observed in healthy individuals and in patients
with essential hypertension and CHD. The concentrations
or the activity of fibrinogen, FVII, FVIII, FXII [141–146],
and D-dimer [146–149] usually increases during acute
psychological stress. Increased fibrinogen levels suggest the
activation of the common pathway of coagulation. Eleva-
tions of FVIII and FXII levels suggest a greater activity of
the intrinsic pathway, whereas elevations of FVII levels
suggest a greater activity of the extrinsic pathway.
Increased D-dimer levels suggest that procoagulant forces
prevail over anticoagulant influences, even though coagu-
lation and fibrinolysis are coexistent with acute mental
stress [10].
In contrast, some studies have reported equivocal
changes in clotting activity resulting from acute psycho-
logical stress. For example, fibrinogen concentration has
not always increased significantly during the Stroop task
[68] and the Trier Social Stress Test (TSST; 144, 150).
However, the results from these studies were in the
expected direction, and nonsignificance likely occurred
due to the low statistical power arising from small sample
sizes. Additionally, some studies have not found a
statistically significant increase in D-dimer during acute
mental stress in men [18, 142, 143, 150] and women [142].
Such discrepancies may be due to the use of different
assays. The aforementioned studies [146–149] that reported
significant increases in D-dimer used enzyme-linked im-
munosorbent assays (ELISA), but other studies [18, 143,
150] used a turbidimetric method, which may have poorer
sensitivity [151] and agreement [152] than ELISA. How-
ever, this does not explain why Steptoe and associates [142]
did not find a significant increase in D-dimer with acute
stress using ELISA. von Känel and colleagues [146–149]
used an ELISA that may be more sensitive to stress-related
changes in D-dimer compared to the ELISA used by
Steptoe and colleagues
An alternative explanation for mixed D-dimer findings is
in the use of different stressors. Steptoe et al. [142] used
counterbalanced 5-min Stroop and 5-min mental arithmetic
tasks, whereas von Känel et al. [18, 143, 150] used the
TSST, an evaluative stressor in which the participants give
a speech and perform mental arithmetic in front of an
audience [153]. In a comprehensive meta-analysis, Dick-
erson and Kemeny [154] concluded that the psychosocial
stress tasks that have unpredictable and social-evaluative
threat components elicit the largest hormonal changes
(namely, cortisol) and have the longest recovery times.
The TSST is characterized by unpredictability and threat of
social evaluation. However, there may not have been a
social-evaluative threat element in the Stroop and mental
arithmetic tasks in the study conducted by Steptoe et al.
[142]. This argument is based on the presupposition that
hormonal changes arising from social-evaluative threat are
driving coagulation changes during acute stress. However,
during a 148-min stress protocol that included a 30-min
baseline period, 13-min TSST, and 105-min recovery
period [150], D-dimer stress reactivity and cortisol reactiv-
ity were unrelated. The lack of relationship between D-
dimer reactivity and cortisol reactivity could be due to the
approximate 30-min lag in cortisol response to a stressor,
whereas D-dimer tends to increase within minutes of the
initiation of a stressor. Thus, cortisol and D-dimer have
peaks that are completely out of phase with each other, and
reactivity should not be expected to coincide. On the other
hand, catecholamine reactivity is related to D-dimer
reactivity, especially given that both have stress responses
that follow similar time courses. In fact, norepinephrine
significantly explained 3.7% of the variance in D-dimer
stress change among healthy men [155]. Altogether, it
appears that D-dimer concentrations increase during acute
stress when D-dimer is assessed via a sensitive ELISA and
the stressor is characterized by unpredictability and social-
evaluative threat.
Equivocal findings have also been reported for vWF and
measures of clotting time. vWF increased significantly
during the Stroop task and mental arithmetic in males [141]
but not in females [156]. It is possible that this difference is
due to the hormonal differences in females during the
different phases of the menstrual cycle, indicating the need
to control for phase of the menstrual cycle when examining
coagulation responses to acute stress. Prothrombin time
(PT) and activated partial thromboplastin time (APTT) are
temporal measures of the extrinsic and intrinsic pathways of
coagulation, respectively. Of the studies examining coagu-
lation times, two studies have reported no change in APTT
during acute psychological stress [9, 150] while another
reported a shortening of APTT [18]. PT showed no change
in one study [143], a shortening trend in another [9], and a
significant shortening in yet another [18]. One possible
explanation for these incongruous findings is that the most
recent study [18] aggregated prothrombotic changes across
two stress sessions, while prior studies only examined
responses at one stress session. Aggregation across multiple
measurements is more likely to yield more robust physio-
logical effects than a single measurement [157].
How acute psychological stress elicits increased coagu-
lation is not fully understood [10, 18]. One possible
mechanism is stress-induced catecholamine spillover and
altered adrenergic receptor functioning. Consistent with this
explanation, the infusion of epinephrine results in the
elevation of clotting activity of various coagulation
markers. von Känel and Dimsdale [132] reviewed studies
examining such effects and found that blood clotting time
(assessed by various means) shortened in nine of 11 studies
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and elevations in vWF antigen were observed in seven of
seven studies. Moreover, FVIII increased in all 15 studies
reviewed and increased significantly in 14 of those studies.
The mean peak increase for FVIII was 206% and was seen
on average after 19 min of infusion. However, in studies
measuring the recovery after termination of infusion, some
noted that FVIII returned to baseline after 30 min [158] and
6 h [159], whereas others showed incomplete recovery after
30 min [160] and 90 min [161]. Along the same lines, the
infusion of isoproterenol (a potent ß-adrenergic stimulator)
in hypertensive individuals leads to a dose–response
increase in vWF [162]. The most likely explanation for
these effects is that epinephrine binds to endothelial β2-
adrenergic receptors, stimulating the release of FVIII and
vWF [132, 148].
As with platelets [123, 134], hypertensive status may be
a mediating or moderating factor for coagulation responses
to acute psychological stress. Exaggerations of stress
reactivity of blood coagulation could provide one possible
mechanism for the increased risk of atherothrombotic
complications in individuals with essential hypertension.
As such, Wirtz and colleagues [163] examined coagulant
stress reactivity and recovery to the TSST in otherwise
healthy middle-aged men with systolic and diastolic
hypertension. FVII, FVIII, fibrinogen, and D-dimer were
assessed from blood drawn immediately before stress,
immediately after stress, and 20 and 60 min after stress.
Compared to normotensive individuals and those with
isolated systolic hypertension (i.e., SBP ≥130), those with
diastolic hypertension (i.e., DBP ≥85), either with or
without systolic hypertension, showed greater FVII and
D-dimer reactivity. Furthermore, those with diastolic
hypertension had delayed recovery of coagulation meas-
ures; FVII, FVIII, and D-dimer were higher at 20 min and
FVIII was higher at 60 min post-stress in those with
diastolic hypertension compared to normotensive individu-
als. These effects remained when controlling for age, body
mass index, resting mean arterial pressure, and resting
coagulation factor levels. The findings of this study suggest
that acute psychological stress causes a prothrombotic state
that is greater in hypertensive than in normotensive
individuals [163]. Thus, hypertensive individuals may be
at a greater risk for developing premature atherosclerosis
because of the magnified bursts of hypercoagulability that
occur during times of stress and builds over a person’s
lifetime. Such an assertion is especially relevant given that,
in healthy men, no habituation of any coagulation factor
responses to acute stress occurred over 3 [143] or 4 weeks
[137] weeks. Though no known study has examined the
habituation of responses in hypertensive individuals, it
seems feasible that such individuals would also not
habituate to acute stressors, leading them to greater risk of
developing premature atherosclerosis. Lending additional
support to a lack of habituation are findings suggesting that
individuals with greater chronic stress (e.g., Alzheimer
caregivers having experienced more negative life events
over 4 weeks) show greater coagulation responses to acute
stress compared to caregivers who reported less negative
life events [164]. Moreover, other markers of chronic stress,
such as low socioeconomic status and low job control [142,
165], appear to be related to a hypercoagulable state during
and/or immediately after a psychosocial stressor. Neverthe-
less, future studies should examine whether habituation of
coagulation responses to acute stress occurs in hypertensive
individuals.
It must be noted that many hemostasis markers assessed
in acute stress studies have long half-lives, lasting for
several hours to several days [166]. In some cases, they
peak much later than when they are typically measured. For
example, after an acute cardiovascular event, vWF levels
typically become elevated at 24 h and peak 48–72 h before
returning to normal 14 days after the event [167].
Therefore, it may not be appropriate to measure vWF
immediately after a stressor. Given that acute psychological
stress is purported to precipitate acute coronary syndromes,
it stands to reason that such markers should be measured in
the days following the laboratory stressor.
Stress-Hemoconcentration and Hemostasis
Notwithstanding sympathetic nervous system mechanisms,
stress-hemoconcentration may play a crucial role in the
observed increases in coagulation during acute psycholog-
ical stress. SBP and DBP reliably increase during acute
stress, which may push the plasma out of the vasculature
into the interstitial spaces, causing hemoconcentration of
coagulation factors. Although a small number of studies
have examined hemoconcentration effects in stress-
coagulation studies, these effects are often overlooked.
This is the most important limitation of the majority of
studies examining the effects of psychological stress on
coagulation factors because, as shown in Table 1, the
molecular weights of most coagulation factors examined in
stress-coagulation studies are greater than 69 kDa [168] and
cannot pass freely through capillary pores. Specifically, the
molecular weights of fibrinogen, prothrombin, FV, FVIII,
FXI, FXII, and FXIII exceed this threshold [168]. More-
over, D-dimer has a molecular weight of 195 kDa [169],
and vWF is an extremely large molecule composed of
numerous 250-kDa subunits with a molecular weight often
exceeding 20,000 kDa [170]. On the other hand, FVII has a
molecular mass of approximately 50 kDa [168]. Theoreti-
cally, FVII should be uninfluenced by stress-
hemoconcentration. However, one must also bear in mind
whether assays are measuring concentrations of a clotting
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factor (e.g., FVII:ag) or its activity (e.g., FVII:C). It is
feasible that a factor could become more active but have no
change or even a decrease in concentration during acute
stress.
Of the few studies that have examined stress-
hemoconcentration effects on coagulation, some have
included hematocrit changes as a covariate when examining
changes in the concentration of coagulation factors during
acute psychological stress [149]. As such, it was concluded
in these studies that the increases in coagulation factors
during acute stress were independent of hemoconcentration.
This approach, however, only controls for variation in
changes in hematocrit rather than actually correcting for
plasma volume shifts. Another approach to examining
stress-hemoconcentration effects on coagulation has been
to calculate Spearman correlations between change scores
of hemoconcentration (i.e., hematocrit, hemoglobin, and
plasma volume) and coagulation measures from baseline to
immediately post-stress [144]. No significant relationships
emerged with this method and, thus, the authors concluded
that stress-hemoconcentration is an unlikely explanation for
the coagulation response to stress. However, the relation-
ships in this study pointed in the right direction for stress-
hemoconcentration effects and the authors acknowledge
that significant associations may have been detected with a
larger sample. Furthermore, correlations are not nearly as
powerful as arithmetic adjustment for plasma volume shifts
[72].
Only one known coagulation study has arithmetically
adjusted for stress-induced plasma volume shifts [18]. In
this study, it was reported that stress-hemoconcentration
significantly altered the plasma levels of prothrombotic
measures in response to the TSST. Specifically, fibrinogen,
FVII, FVIII, FXII, and vWF levels all became elevated
immediately after the TSST relative to baseline when there
was no adjustment for plasma volume shifts. However,
when taking plasma volume shifts into account, none of
these increases remained significant. In contrast, fibrinogen
and FVII levels even decreased significantly when correct-
ing for hemoconcentration, which is consistent with studies
examining changes in these factors during exercise [171].
However, given that FVII has a molecular weight of
50 kDa, it is puzzling why FVII showed this pattern of
results.
Without correction for plasma volume shifts, APTT
showed a shortening trend in this study as well, which
suggests faster initiation of the intrinsic pathway of blood
coagulation during acute stress, but PT did not change,
suggesting that acute stress had no effect on clotting time of
the extrinsic pathway. When adjusting for plasma volume
shifts, however, a significant decrease was found for APTT,
indicating faster clotting via the intrinsic pathway. On the
other hand, PT was longer when correcting for plasma
volume shifts, suggesting slower clotting via the extrinsic
pathway [18].
When comparing baseline levels of coagulation measures
to levels at 45 min post-stress (i.e., recovery), similar
observations were noted, with the notable exception of FVIII
which was the only clotting factor with elevations during
recovery that survived arithmetic correction [18]. Moreover,
FVIII levels remained higher when taking into account
plasma volume changes during recovery. Together with the
previous observation that FVIII remained elevated 2 h post-
stress compared to baseline levels [143], these results suggest
that FVIII is actually or “genuinely” activated during the
time immediately after acute psychological stress. Correcting
for plasma volume changes in APTT and PT from baseline
to recovery resulted in changes opposite to those seen
between baseline and immediately post-stress levels. That is,
APTT was prolonged and PT was shortened [18]. Given that
APTT and PT are measures of time, these results, however,
may be misleading and must be interpreted with extreme
caution. Dill and Costill’s [39] arithmetic correction for
plasma volume shifts adjusts for the amount of plasma that
leaves the vasculature during acute stress and should be used
when examining changes in the concentration of a param-
eter. However, the arithmetic adjustment has no time
component. Similarly, an arithmetic correction may be
inappropriate when examining the activity or activation of
clotting factors as opposed to concentrations. Changes in
plasma volume may influence clotting time and clotting
activity differently than the concentrations of clotting factors.
Therefore, the use of mathematical correction for these
measures is questionable.
A more biologically relevant method for correcting for
hemoconcentration effects on clotting time and clotting
activity may be to physically reconstitute plasma collected
during a stressor with either plasma from rest or with
physiological saline so that the plasma volume during stress
becomes equivalent to the plasma volume at rest. A recent
pilot study suggests that this may indeed be the case [172].
PT, APTT, FVIII:C, and fibrinogen were determined at
baseline and immediately after a mental arithmetic stressor
in ten young males. Plasma obtained immediately after the
math task was reconstituted with baseline plasma and
physiological saline equal to the amount of plasma lost
during the stress-induced plasma volume shift. Paired t-tests
showed that uncorrected PT and APTT immediately after
the stressor were significantly shorter and that uncorrected
FVIII:C was significantly higher than during baseline.
Repeated-measures ANOVAs revealed that math APTT
was not significantly shorter than baseline APTT when
adjusting arithmetically for plasma volume changes or with
either reconstitution technique. Similar to previous results
[18], math PT became significantly longer than baseline PT
when adjusting arithmetically for plasma volume shifts.
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However, PT was no longer significantly different than
baseline PT when adjusting with either reconstitution
technique. No overall effects were found for FVIII:C or
fibrinogen, possibly due to low power arising from the
small sample size [172]. Based on these preliminary results,
mathematical adjustment appears to over-correct for plasma
volume shifts when examining clotting time of the extrinsic
pathway of coagulation (i.e., PT). Future studies should
attempt to replicate and extend these findings to larger
samples, different stressors, and different coagulation
markers (e.g., D-dimer and vWF).
Conclusions
The elucidation of mechanisms linking acute stress to the
triggering of atherothrombosis resulting in acute coronary
syndromes is a crucial issue in psychohematology and
cardiovascular behavioral medicine. One promising link is
through elevated coagulation activity. The ensuing hyper-
coagulable state after acute stress may be more likely to
cause an atherothrombotic event, especially when athero-
sclerosis or endothelial dysfunction is already present [10,
132]. Heightened sympathetic arousal could crucially shift
the hemostatic balance toward a hypercoagulable condition
in patients with atherosclerosis due to antithrombotic and
fibrinolytic irregularities [10]. However, how heightened
sympathetic arousal exerts its effects on hemostatic balance
remains unclear. Possibilities include the activation of
platelets and clotting factors by catecholamines and
hemoconcentration of clotting factors resulting from plasma
volume shifts. Studies attempting to address this issue have
shown that acute stress results in a hypercoagulable state
and that this state is probably exaggerated in hypertensive
individuals. It is unclear whether the observed increases in
the concentrations and activity of various coagulation
factors during acute stress result from hemoconcentration
or from actual activation of the coagulation system.
Regardless of whether the elevated concentrations of
hemostasis factors following acute stress are due to actual
activation or to hemoconcentration, the endothelium
becomes exposed to more of that cell. Such an intravascular
environment has clear clinical implications. From a clinical
standpoint, elevated clotting activity resulting from acute
stress may promote an atherogenic vascular environment
and is harmful no matter what the mechanism.
Different studies employing differing methods for
correcting for stress-hemoconcentration effects have
reported equivocal findings. Moreover, adjusting for hemo-
concentration effects on parameters of coagulation time
(i.e., PT and APTT) arithmetically [39] may over-correct,
resulting in time becoming longer. It is plausible that the
arithmetic correction for plasma volume shifts is also
inappropriate when examining clotting activity during acute
psychological stress. Therefore, arithmetic correction may
only be useful when measuring concentrations. Future
studies should examine whether alternative methods of
adjusting for hemoconcentration effects, such as the
reconstitution method previously discussed, are valuable.
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